MyFinsight
Home
About
Contact
imrx: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, IMRX has $241,056,266 in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Subscribe for Financial Insights
Page 1
Unit: Dollar
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
241,056,266
40,056,468
Total stockholders' equity
227,976,432
28,936,037
Total liabilities and stockholders' equity
241,056,266
40,056,468
Unit: Dollar
Page 1
Subscribe for Financial Insights
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaids and other
current assets
$1,538,752
Cash and cash
equivalents
$227,563,077
Other assets
$631,297
Right-of-use assets
$3,411,693
Intangible asset, net
$328,463
Goodwill
$6,690,431
Property and equipment,
net
$892,553
Total current assets
$229,101,829
Total assets
$241,056,266
Total liabilities and
stockholders' equity
$241,056,266
Total stockholders'
equity
$227,976,432
Total liabilities
$13,079,834
Accumulated deficit
-$268,740,074
Additional paid-in capital
$496,653,023
Lease liabilities,
net of current...
$3,534,569
Total current
liabilities
$9,545,265
Common stock-Common
Class A
$63,483
Lease liabilities
$381,760
Other liabilities
$80,089
Accrued expenses
$7,483,142
Accounts payable
$1,600,274
Subscribe for Financial Insights
Immuneering Corp (IMRX)
Immuneering Corp (IMRX)